Skip to main navigation Skip to search Skip to main content

Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer

  • Else Maae
  • , Dorte Aalund Olsen
  • , Karina Dahl Steffensen
  • , Erik Hugger Jakobsen
  • , Ivan Brandslund
  • , Flemming Brandt Sørensen
  • , Anders Jakobsen

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Placenta growth factor (PlGF) and vascular endothelial growth factor A (VEGF-A) are angiogenic growth factors interacting competitively with the same receptors. VEGF-A is essential in both normal and pathologic conditions, but the functions of PlGF seem to be restricted to pathologic conditions such as ischemic heart disease, arthritis and tumor growth. Angiogenesis is a complex process with several growth factors involved. Because PlGF modulates VEGF-A responses, we investigated their mutual relationship and impact on breast cancer prognosis. Quantitative PlGF and VEGF-A levels were measured in 229 tumor tissue specimen from primarily operated patients with unilateral breast cancer. Non-malignant breast tissue was also dissected near the tumor and quantitative measurements were available for 211 patients. PlGF and VEGF-A protein levels in homogenized tissue lysates were analyzed using the Luminex system. We found significantly higher median levels of PlGF and VEGF-A in tumor tissue compared to non-malignant tissue (PlGF: 69.8 vs. 31.4 pg/mg, p
Original languageEnglish
JournalBreast Cancer Research and Treatment
Volume133
Issue number1
Pages (from-to)257-265
Number of pages9
ISSN0167-6806
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer'. Together they form a unique fingerprint.

Cite this